• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Cardiff teases onvansertib efficacy in colorectal cancer

    ENDPTS

    Cardiff Oncology Announces Plans for a Randomized Trial in mCRC

    PRNEWSWIRE

    Cardiff Oncology Announces Data from Program in KRAS-mutated mCRC

    PRNEWSWIRE

    Cardiff Oncology Shows Data Showing Combo of PARP Inhibition with Onvansertib

    PRNEWSWIRE

    Cardiff Oncology Announces New Data from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival

    PRESS RELEASE

    Pfizer invests $15M in Cardiff to bankroll Amgen KRAS challenger

    PRECISIONONCOLOGYNEWS

    Cardiff Announces 1st Patient Dosed in Ph2 Trial of Onvansertib+ Irinotecan+5-FU

    BIOSPACE

    Cardiff Oncology Presents Data at ASH Demonstrating Safety and Anti-Leukemic

    PRNEWSWIRE

    Cardiff Oncology Announces Expanded Access Program for Onvansertib in KRAS

    PRNEWSWIRE

    Cardiff Oncology Enters Agreement with PoC to Fund Ph2 Trial of Onvansertib

    PRNEWSWIRE

    Onvansertib Trial in KRAS-Mutated Colorectal Cancer Demonstrates Tumor

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.